Malignant Urethral Neoplasm — Trials

Malignant Urethral Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02122172	Afatinib in Advanced Refractory Urothelial Cancer	terminated	Phase 2	32	University of ChicagoOTHER	1	Apr 25, 2025	clinicaltrials
NCT03397394	Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma(ATLAS)	terminated	Phase 2	97	pharmaand GmbHINDUSTRY	6	Jun 9, 2023	clinicaltrials